Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811261 · ClinicalTrials.gov registry record · Early Phase 1
u-STOP LVAD Bleed: Utilization of Umbilical Cord Lining Stem Cells (ULSCs) To Prevent Left Ventricular Assist Device (LVAD) Associated Angiodysplastic Bleeding
A Early Phase 1 study of Angiodysplastic Bleeding, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT04811261 is a Early Phase 1 study of Angiodysplastic Bleeding that has completed, run by University of Florida. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04811261, a Early Phase 1 study of Angiodysplastic Bleeding, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase I, single ascending dose, first in human, open-label, non-controlled, dose-escalation trial that will investigate intravenous infusions of Umbilical cord lining stem cells (UCLSCs) in Left Ventricular Assist Device (LVAD) patients. This study will recruit patients from the Advanced Heart Failure and LVAD Clinic at the University of Florida, including recently implanted patients, as well as patients on chronic long-term support, with the goal of enrolling up to 9 subjects to participate in the study.
Conditions Studied
Interventions
- DRUG Intravenous Infusion of UCLSCs
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2023-07-27 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04811261
The ClinicalTrials.gov registry entry for NCT04811261 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Angiodysplastic Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Intravenous Infusion of UCLSCs is the first listed.
NCT04811261 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04811261 about?
NCT04811261 is a clinical study titled "u-STOP LVAD Bleed: Utilization of Umbilical Cord Lining Stem Cells (ULSCs) To Prevent Left Ventricular Assist Device (LVAD) Associated Angiodysplastic Bleeding". This is a Phase I, single ascending dose, first in human, open-label, non-controlled, dose-escalation trial that will investigate intravenous infusions of Umbilical cord lining stem cells (UCLSCs) in Left Ventricular Assist Device (LVAD) patients. This study will recruit patients from the Advanced ...
What is the current status of trial NCT04811261?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2021-11-01. Estimated completion is 2023-07-27.
What conditions does trial NCT04811261 study?
This clinical trial studies the following conditions: Angiodysplastic Bleeding.
What interventions are being tested in trial NCT04811261?
The interventions under investigation include: Intravenous Infusion of UCLSCs (DRUG).
Who is sponsoring clinical trial NCT04811261?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04811261 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.